Discovery of a novel and potent, and urea isostere inhibitors series of dianilinopyrimidineurea of VEGFR2 tyrosine kinase

被引：33

作者：

Sammond, DM ^{[1
]}

Nallor, KE ^{[1
]}

Veal, JM ^{[1
]}

Nolte, RT ^{[1
]}

Wang, LP ^{[1
]}

Knick, VB ^{[1
]}

Rudolph, SK ^{[1
]}

Truesdale, AT ^{[1
]}

Nartey, EN ^{[1
]}

Stafford, JA ^{[1
]}

Kumar, R ^{[1
]}

Cheung, M ^{[1
]}

机构：

[1] GlaxoSmithKline, Res Triangle Pk, NC 27709 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2005年 / 15卷 / 15期

关键词：

VEGFR2; FLK-1; KDR; kinase inhibitor;

D O I：

10.1016/j.bmcl.2005.05.096

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

引用

页码：3519 / 3523

页数：5

共 50 条

[21] Rational Design and Synthesis of a Novel Series of Thiosemicarbazone-Containing Quinazoline Derivatives as Potential VEGFR2 Inhibitors
Sandor, Alexandru
Crisan, Ovidiu
Marc, Gabriel
Fizesan, Ionel
Ionut, Ioana
Moldovan, Cristina
Stana, Anca
Oniga, Ilioara
Pirnau, Adrian
Vlase, Laurian
Petru, Andreea-Elena
Crestin, Ionut-Valentin
Jijie, Alex-Robert
Tiperciuc, Brindusa
Oniga, Ovidiu
PHARMACEUTICS, 2025, 17 (02)
[22] Exploration of novel VEGFR2 tyrosine kinase inhibitors via design and synthesis of new alkylated indolyl-triazole Schiff bases for targeting breast cancer
Nafie, Mohamed S.
Boraei, Ahmed T. A.
BIOORGANIC CHEMISTRY, 2022, 122
[23] Anti-Angiogenic Therapy: Strategies to Develop Potent VEGFR-2 Tyrosine Kinase Inhibitors and Future Prospect
Shi, Leilei
Zhou, Jianfeng
Wu, Jifeng
Shen, Yuemao
Li, Xun
CURRENT MEDICINAL CHEMISTRY, 2016, 23 (10) : 1000 - 1040
[24] Discovery of 4,6-Disubstituted Pyrimidine Derivatives as Novel Dual VEGFR2/FGFR1 Inhibitors
Zhang, Jin-Yang
Xue, Wen-Jun
Wang, Min
Li, Wen
Dong, Ru
Li, Ming-Tao
Sun, Li-Ping
CHEMISTRY & BIODIVERSITY, 2021, 18 (05)
[25] The VEGFR2 receptor tyrosine kinase undergoes constitutive endosome-to-plasma membrane recycling
Jopling, Helen M.
Howell, Gareth J.
Gamper, Nikita
Ponnambalam, Sreenivasan
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2011, 410 (02) : 170 - 176
[26] Design, synthesis, and evaluation of imidazo[1,2-b]pyridazine derivatives having a benzamide unit as novel VEGFR2 kinase inhibitors
Miyamoto, Naoki
Oguro, Yuya
Takagi, Terufumi
Iwata, Hidehisa
Miki, Hiroshi
Hori, Akira
Imamura, Shinichi
BIOORGANIC & MEDICINAL CHEMISTRY, 2012, 20 (24) : 7051 - 7058
[27] Rhamnazin, a novel inhibitor of VEGFR2 signaling with potent antiangiogenic activity and antitumor efficacy
Yu, Yao
Cai, Wei
Pei, Chong-gang
Shao, Yi
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2015, 458 (04) : 913 - 919
[28] Potent and selective Bruton's tyrosine kinase inhibitors: Discovery of GDC-0834
Young, Wendy B.
Barbosa, James
Blomgren, Peter
Bremer, Meire C.
Crawford, James J.
Dambach, Donna
Gallion, Steve
Hymowitz, Sarah G.
Kropf, Jeffrey E.
Lee, Seung H.
Liu, Lichuan
Lubach, Joseph W.
Macaluso, Jen
Maciejewski, Pat
Maurer, Brigitte
Mitchell, Scott A.
Ortwine, Daniel F.
Di Paolo, Julie
Reif, Karin
Scheerens, Heleen
Schmitt, Aaron
Sowell, C. Gregory
Wang, Xiaojing
Wong, Harvey
Xiong, Jin-Ming
Xu, Jianjun
Zhao, Zhongdong
Currie, Kevin S.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 25 (06) : 1333 - 1337
[29] MicroRNAs Targeting HIF-2α, VEGFR1 and/or VEGFR2 as Potential Predictive Biomarkers for VEGFR Tyrosine Kinase and HIF-2α Inhibitors in Metastatic Clear-Cell Renal Cell Carcinoma
Kinget, Lisa
Roussel, Eduard
Verbiest, Annelies
Albersen, Maarten
Rodriguez-Antona, Cristina
Grana-Castro, Osvaldo
Inglada-Perez, Lucia
Zucman-Rossi, Jessica
Couchy, Gabrielle
Job, Sylvie
de Reynies, Aurelien
Laenen, Annouschka
Baldewijns, Marcella
Beuselinck, Benoit
CANCERS, 2021, 13 (12)
[30] Novel potent substituted 4-amino-2-thiopyrimidines as dual VEGFR-2 and BRAF kinase inhibitors
Abdel-Mohsen, Heba T.
Omar, Mohamed A.
El Kerdawy, Ahmed M.
Mahmoud, Abeer E. E.
Ali, Mamdouh M.
El Diwani, Hoda I.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 179 : 707 - 722

← 1 2 3 4 5 →